206 related articles for article (PubMed ID: 33128348)
1. 20(S)-Protopanaxadiol inhibits epithelial-mesenchymal transition by promoting retinoid X receptor alpha in human colorectal carcinoma cells.
Lu Z; Liu H; Fu W; Wang Y; Geng J; Wang Y; Yu X; Wang Q; Xu H; Sui D
J Cell Mol Med; 2020 Dec; 24(24):14349-14365. PubMed ID: 33128348
[TBL] [Abstract][Full Text] [Related]
2. mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis.
Cheng X; Shen T; Liu P; Fang S; Yang Z; Li Y; Dong J
BMC Cancer; 2022 Nov; 22(1):1151. PubMed ID: 36348305
[TBL] [Abstract][Full Text] [Related]
3. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
4. MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
Fan H; Liu X; Zheng WW; Zhuang ZH; Wang CD
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4853-4859. PubMed ID: 29164577
[TBL] [Abstract][Full Text] [Related]
5. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
[TBL] [Abstract][Full Text] [Related]
6. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
8. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
Wang Y; Sun N; Lu C; Bei Y; Qian R; Hua L
Int J Oncol; 2017 Jun; 50(6):2191-2199. PubMed ID: 28498393
[TBL] [Abstract][Full Text] [Related]
10. Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183.
Shen T; Cheng X; Liu X; Xia C; Zhang H; Pan D; Zhang X; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4038-4045. PubMed ID: 31608699
[No Abstract] [Full Text] [Related]
11. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
12. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
Ayinde O; Wang Z; Griffin M
Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
[TBL] [Abstract][Full Text] [Related]
15. Suppression of retinoid X receptor alpha and aberrant β-catenin expression significantly associates with progression of colorectal carcinoma.
Zhang F; Meng F; Li H; Dong Y; Yang W; Han A
Eur J Cancer; 2011 Sep; 47(13):2060-7. PubMed ID: 21561764
[TBL] [Abstract][Full Text] [Related]
16. microRNA-145 downregulates SIP1-expression but differentially regulates proliferation, migration, invasion and Wnt signaling in SW480 and SW620 cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
J Cell Biochem; 2018 Feb; 119(2):2022-2035. PubMed ID: 28833449
[TBL] [Abstract][Full Text] [Related]
17. ZNF326 promotes colorectal cancer epithelial-mesenchymal transition.
Yang Y; Yan T; Han Q; Zhang M; Zhang Y; Luo Y; Wei L; Li P; Wang E
Pathol Res Pract; 2021 Sep; 225():153554. PubMed ID: 34332402
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells.
Kishore C; Sundaram S; Karunagaran D
Chem Biol Interact; 2019 Aug; 309():108725. PubMed ID: 31238027
[TBL] [Abstract][Full Text] [Related]
19. CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer.
Raposo TP; Comes MS; Idowu A; Agit B; Hassall J; Fadhil W; Nica R; Ecker R; Yao T; Ilyas M
Exp Mol Pathol; 2018 Jun; 104(3):190-198. PubMed ID: 29653092
[TBL] [Abstract][Full Text] [Related]
20. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.
Hu XT; Xing W; Zhao RS; Tan Y; Wu XF; Ao LQ; Li Z; Yao MW; Yuan M; Guo W; Li SZ; Yu J; Ao X; Xu X
J Exp Clin Cancer Res; 2020 Dec; 39(1):270. PubMed ID: 33267897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
